JPMorgan Chase & Co’s Allena Pharmaceuticals, Inc. Common Stock ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-11
| Closed | – | – | 5211 |
|
|
2020
Q3 | $0 | Buy |
+11
| New | – | ﹤0.01% | 5134 |
|
|
2019
Q4 | – | Sell |
-56,579
| Closed | -$223K | – | 4938 |
|
|
2019
Q3 | $223K | Buy |
56,579
+9,678
| +21% | +$38.1K | ﹤0.01% | 3707 |
|
|
2019
Q2 | $195K | Sell |
46,901
-172,160
| -79% | -$716K | ﹤0.01% | 3780 |
|
|
2019
Q1 | $1.54M | Sell |
219,061
-14,999
| -6% | -$105K | ﹤0.01% | 2792 |
|
|
2018
Q4 | $1.28M | Sell |
234,060
-1,265
| -0.5% | -$6.89K | ﹤0.01% | 2895 |
|
|
2018
Q3 | $2.53M | Sell |
235,325
-3,885
| -2% | -$41.7K | ﹤0.01% | 2660 |
|
|
2018
Q2 | $3.12M | Buy |
239,210
+43,439
| +22% | +$566K | ﹤0.01% | 2541 |
|
|
2018
Q1 | $2.16M | Sell |
195,771
-162,072
| -45% | -$1.79M | ﹤0.01% | 2707 |
|
|
2017
Q4 | $3.6M | Buy |
+357,843
| New | +$3.6M | ﹤0.01% | 2446 |
|